[go: up one dir, main page]

CL2015001159A1 - Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción. - Google Patents

Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción.

Info

Publication number
CL2015001159A1
CL2015001159A1 CL2015001159A CL2015001159A CL2015001159A1 CL 2015001159 A1 CL2015001159 A1 CL 2015001159A1 CL 2015001159 A CL2015001159 A CL 2015001159A CL 2015001159 A CL2015001159 A CL 2015001159A CL 2015001159 A1 CL2015001159 A1 CL 2015001159A1
Authority
CL
Chile
Prior art keywords
production method
type
enzymatic hydrolysis
nutritional supplement
collagen hydrolyzate
Prior art date
Application number
CL2015001159A
Other languages
English (en)
Inventor
Steffen Oesser
Monika Giesen-Wiese
Hans-Ulrich Frech
Stephan Hausmanns
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49578271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015001159(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of CL2015001159A1 publication Critical patent/CL2015001159A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/342—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of collagen; of gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
CL2015001159A 2012-11-06 2015-04-30 Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción. CL2015001159A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012110612.6A DE102012110612A1 (de) 2012-11-06 2012-11-06 Kollagenhydrolysat und dessen Verwendung

Publications (1)

Publication Number Publication Date
CL2015001159A1 true CL2015001159A1 (es) 2015-08-28

Family

ID=49578271

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015001159A CL2015001159A1 (es) 2012-11-06 2015-04-30 Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción.

Country Status (13)

Country Link
US (1) US10364283B2 (es)
EP (1) EP2916855B1 (es)
JP (1) JP6272891B2 (es)
CN (1) CN104768566B (es)
AU (1) AU2013343685B2 (es)
BR (1) BR112015009473B1 (es)
CL (1) CL2015001159A1 (es)
DE (1) DE102012110612A1 (es)
ES (1) ES2587928T3 (es)
MX (1) MX2015005649A (es)
PL (1) PL2916855T3 (es)
RU (1) RU2671401C2 (es)
WO (1) WO2014072235A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013104897A1 (de) * 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
DE102014117036A1 (de) 2014-11-20 2016-05-25 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
DE202014105602U1 (de) 2014-11-20 2015-11-23 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
RU2659383C2 (ru) * 2015-10-20 2018-06-29 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Биоактивный гидрогель для регенерации кожи
DE102015121923A1 (de) * 2015-12-16 2017-06-22 Gelita Ag Gießmasse und Verfahren für die Herstellung von Gelatineprodukten
GR1009140B (el) * 2016-01-12 2017-10-20 Σωτηρης Γεωργιου Χορτομαρης Συμπληρωμα διατροφης με χοιρινο και βοϊο κολλαγονο υδρολυμενο και ζελατινη
EP3411016B1 (en) 2016-02-03 2024-09-11 Fresenius Kabi Deutschland GmbH High caloric, high protein nutritional formula
NL2017219B1 (en) * 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
CN110691604A (zh) * 2017-03-15 2020-01-14 罗赛洛公司 水解胶原蛋白肽和共生微生物的组合物及其方法
CN107083415A (zh) * 2017-05-27 2017-08-22 四川汇宇生物技术有限公司 一种明胶的生产方法
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
DE102018120420A1 (de) * 2018-08-22 2020-02-27 Gelita Ag Proteinriegel
DE102019202606A1 (de) * 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102019207859A1 (de) 2018-12-21 2020-06-25 Gelita Ag Synthetische und rekombinant hergestellte Kollagenpeptide mit biologischer Wirksamkeit
DE102020210725A1 (de) 2019-10-31 2021-05-06 Gelita Ag Ernährungsphysiologisch optimiertes Kollagenpeptid
DE102019130196A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Kollagenpeptiden aus Knochen, und hergestellte Kollagenpeptide
DE102019130197A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Knochengelatine, und hergestellte Knochengelatine
US20210145764A1 (en) * 2019-11-15 2021-05-20 Brigham Young University Compositions of cannabidiol (cbd), and/or polyphenols, and methods for the prevention and/or treatment of skin, muscle, nerve and inflammatory disorders, and biological factors and functions in mammals
CA3164511A1 (en) 2020-01-13 2021-07-22 Chathurada GAJADEERA Turkey collagen hydrolysates and methods of making
DE102020126594A1 (de) * 2020-10-09 2022-04-14 Gelita Ag Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
BE1030791B1 (nl) * 2022-08-31 2024-07-29 Rousselot B V Gebruik van collageenhydrolysaat bij preventie en/of behandeling van post intensive care syndroom (PICS)
DE202023107635U1 (de) 2023-12-22 2024-02-08 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
CN120060939B (zh) * 2025-01-26 2025-12-02 大连理工大学 一种纳米孪晶铜电镀添加剂及电镀液

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003788A1 (en) * 1988-10-14 1990-04-19 Basf Corporation Method of making a free-flowing spray-dried edible powder comprising an oil
US5120761A (en) * 1988-10-14 1992-06-09 Finnan Jeffrey L Method of making a free-flowing spray dried edible powder comprising an oil
JPH09501678A (ja) * 1993-08-13 1997-02-18 ベイヤー、コーポレーション かむ錠剤の芳香増進剤としての加水分解ゼラチン
FR2720067B1 (fr) 1994-05-17 1996-08-02 Dielen Lab Hydrolysat de protéines d'animaux marins, procédé d'obtention et applications.
US5948766A (en) * 1994-08-23 1999-09-07 Dgf Stoess Ag Use of tasteless, hydrolyzed collagen and agent containing the same
JP4609807B2 (ja) 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) * 1997-06-18 1999-01-19 Zenyaku Kogyo Kk 骨粗鬆症予防・治療剤
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
GB0031065D0 (en) * 2000-12-20 2001-01-31 Univ Cardiff Preservation of cells
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
US7485323B2 (en) * 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
JP4975751B2 (ja) 2005-10-13 2012-07-11 グ、ジェニファー、エル． ミネラル・コラーゲン・キレートおよびその製造方法と使用方法
JP5689222B2 (ja) * 2006-11-15 2015-03-25 株式会社明治 コラーゲンペプチド組成物及びこれを含有する飲食品
WO2008075333A2 (en) * 2006-12-18 2008-06-26 Zeev Pam Edible compositions for preventing hair loss
JP2008247809A (ja) 2007-03-30 2008-10-16 Yaizu Suisankagaku Industry Co Ltd コラーゲン錠剤
FR2927336B1 (fr) * 2008-02-12 2010-05-21 Cie Des Peches Saint Malo Sant Hydrolysat de proteines de poissons presentant une activite de stimulation et de maintien du capital osseux, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention
DE102009030351A1 (de) 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
CN102094056B (zh) 2009-12-14 2013-04-03 包头东宝生物技术股份有限公司 可溶性胶原蛋白的制备方法
JP5370225B2 (ja) * 2010-03-18 2013-12-18 株式会社デンソーウェーブ ロボットのアーム連結装置
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
DE102011000997A1 (de) * 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
US8603183B2 (en) * 2011-06-22 2013-12-10 Shinn Jyh Ding Bilayered bone graft device

Also Published As

Publication number Publication date
AU2013343685A8 (en) 2015-07-02
RU2671401C2 (ru) 2018-10-31
CN104768566A (zh) 2015-07-08
MX2015005649A (es) 2015-08-20
AU2013343685B2 (en) 2018-03-29
JP2015534812A (ja) 2015-12-07
AU2013343685A1 (en) 2015-05-21
EP2916855A1 (de) 2015-09-16
EP2916855B1 (de) 2016-07-27
PL2916855T3 (pl) 2017-08-31
DE102012110612A1 (de) 2014-05-08
ES2587928T3 (es) 2016-10-27
US10364283B2 (en) 2019-07-30
US20150232534A1 (en) 2015-08-20
JP6272891B2 (ja) 2018-01-31
BR112015009473A2 (pt) 2017-07-04
BR112015009473B1 (pt) 2022-10-04
CN104768566B (zh) 2018-06-29
WO2014072235A1 (de) 2014-05-15
RU2015121573A (ru) 2016-12-27

Similar Documents

Publication Publication Date Title
CL2015001159A1 (es) Hidrolizado de colágeno producido por hidrólisis enzimática de gelatina de hueso tipo b; complemento nutricional que lo comprende; y método de producción.
EP3473726B8 (en) Fermentation technique to improve production level of recombinant human collagen
BR112016024939A2 (pt) processo para hidrólise enzimática de material lignocelulósico e fermentação de açúcares.
BR112015002940A2 (pt) microorganismos e métodos para a produção de ácidos graxos e produtos derivados de ácidos graxos.
SG10201911348UA (en) Chitin, hydrolysate and method for the production of one or more products of interest from insects by means of enzymatic hydrolysis
EP3022310A4 (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
SG10201607565QA (en) Enzymatic Omega-Oxidation And Omega-Amination Of Fatty Acids
BR112013016187A2 (pt) Produtos nutricionais compreendendo beta- hidróxi-beta metilbutirato de cálcio e ácido linoléico conjungado.
BR112012001465A2 (pt) método de modulação de ácidos de cadeia ramificada e usos desses.
EP2997154A4 (en) Enhancing enzymatic hydrolysis by enzymatic preconditioning
BR112015001229A2 (pt) método de produção comercial de hidrolisato de queratina, de degradação de queratina e de produção de ração animal, usos de uma protease e de hidrolisato de queratina, hidrolisato de queratina, composição de aditivo alimentar e alimento
SG11201404463PA (en) Enzymatic process for fat and oil hydrolysis
BR112013019677A2 (pt) composições nutricionais altamente protéicas e métodos de fazer e usar as mesmas
BR112015001227A2 (pt) métodos de produção de hidrolisato de queratina, de degradação de queratina e de produção de ração animal, usos de uma composição e de hidrolisato de queratina, hidrolisato de queratina, composição de aditivo alimentar, alimento e produto.
EP2739165A4 (en) TRACE ELEMENT SUPPLEMENTS
PL2785420T3 (pl) Kosmetyczne zastosowanie hydrolizatu kolagenu
BR112017012813A2 (pt) processo para hidrólise enzimática de material lignocelulósico e fermentação de açúcares.
MX2016002314A (es) Composiciones comestibles masticables.
EP3292498A4 (en) Using trusted platform module to build real time indicators of attack information
IT1403244B1 (it) Procedimento per la produzione di lipidi da biomassa.
PT2632096T (pt) Método de certificação da entrega de mensagens eletrónicas
CL2013001841A1 (es) Reactor de membrana para la fabricacion de hidrolizados de proteina vegetal; metodo para la fabricacion de hidrolizados de proteina vegetal; e hidrolizado de proteina vegetal.
BR112012018945A2 (pt) embalagem com rótulo tridimensional e o método de sua fabricação
MX2021012080A (es) Composicion, formulas probioticas y metodos para favorecer la digestion y mejorar la nutricion en la apicultura.
IN2013CH02496A (es)